Back

PRIME Education, Inc. (PRIME®)

  • Muscular Atrophy, Spinal

Navigating the Evolving Treatment Landscape in SMA: An Interactive Clinical Decision-Making Simulation

Spinal muscular atrophy (SMA) is a rare, genetic neuromuscular disorder that presents complex challenges in treatment selection, therapy administration, and long-term monitoring. Are you confident in your current approach to managing patients with SMA?In this interactive Clinical Decision-Making Simulation, you will manage a realistic SMA case, applying the latest evidence on gene replacement therapy to guide patient-centered care.Navigate critical decision points including:Identifying optimal therapies for patients with SMAEvaluating eligibility, administration, and monitoring requirements for gene replacement therapyAssessing outcomes using standardized motor function scales and patient-reported outcome measuresCoordinating multidisciplinary care and navigating transitions from pediatric to adult healthcare systems.After each decision point, review expert commentary supported by the latest evidence, see how you stack up against the knowledge of your peers, and access downloadable summaries of key evidence.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.25 creditsAMA PRA Category 1 Credit™Up to 0.25 creditsNursingUp to 0.25 creditsPharmacyUp to 0.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.25 credits
  • Commercial Support
  • Released
    Aug 26, 2026
  • Last day to claim credit
    Aug 26, 2027 11 months left